Concepedia
1
Publications
18
Citations
H-Index
2024
Active since
Affiliations
Mitsubishi Corporation (United Kingdom)(Current)
Yoshiyasu Ohta is an author at Mitsubishi Corporation (United Kingdom).
Publications per year
2024–2024
First‐in‐human study evaluating safety, pharmacokinetics, and pharmacodynamics of lorundrostat, a novel and highly selective aldosterone synthase inhibitor
H. Shimizu, Michael A. Tortorici, Yoshiyasu Ohta et al. · Clinical and Translational Science · 2024 · 18 citations · Full text
Rows per page
1–1 of 1